Science Explorer Back to mapMap
Discussion
Company · Madrid · Spain

PharmaMar (Spain)

In research, PharmaMar (Spain) stands highest in Biochemistry, Genetics and Molecular Biology (#4,389 of 5,801 worldwide), Life Sciences (#8,883 of 11,023 worldwide) and Health Sciences (#15,778 of 16,688 worldwide), over all time.

World rank, all time
#32,946
of 34,923
Rank in Spain
#627
of 646
Research works
337
▲ 14% vs 2018-21
Citations
8.9k
26.3 per fractional work
Top-10% rate
4.7%
all institutions 10.0%
vs its own fields
0.85×
1.00× is exactly expected
Open access
30%
world 40%
International
36%
world 18%

What is PharmaMar (Spain) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Biochemistry, Genetics and Molecular BiologyField #4,389 of 5,801 12.3%135
Life SciencesDomain #8,883 of 11,023 11.7%156
Health SciencesDomain #15,778 of 16,688 10.6%130
MedicineField #14,080 of 14,558 10.7%128

Each strip is that field's whole ranked pool, with the notch where PharmaMar (Spain) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does PharmaMar (Spain) work in?

In 2022-now, 55% of research at PharmaMar (Spain) is in Health Sciences, 32% in Life Sciences. Its largest fields are Medicine (54%), Biochemistry, Genetics and Molecular Biology (26%), Chemistry (7%). It does 2.0× the world's share of Health Sciences.

Health Sciences: 23 fractional works · 54.7% of its workMedicine: 23 fractional works · 54.3% of its workOncology: 8 fractional works · 19.9% of its workPulmonary and Respiratory Medicine: 3 fractional works · 8.1% of its workPharmacology: 3 fractional works · 7.0% of its workEpidemiology: 2 fractional works · 4.0% of its workPathology and Forensic Medicine: 1 fractional works · 2.6% of its workGeriatrics and Gerontology: 1 fractional works · 2.4% of its workSurgery: 1 fractional works · 1.3% of its workPsychiatry and Mental health: 1 fractional works · 1.3% of its workRheumatology: 0 fractional works · 1.1% of its workInfectious Diseases: 0 fractional works · 0.9% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.8% of its workHematology: 0 fractional works · 0.7% of its workNeurology: 0 fractional works · 0.6% of its workReproductive Medicine: 0 fractional works · 0.5% of its workPhysiology: 0 fractional works · 0.5% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.5% of its workObstetrics and Gynecology: 0 fractional works · 0.3% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.3% of its workBiochemistry: 0 fractional works · 0.3% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.3% of its workAnesthesiology and Pain Medicine: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.7% of its workNursing: 0 fractional works · 0.3% of its workNutrition and Dietetics: 0 fractional works · 0.3% of its workVeterinary: 0 fractional works · 0.1% of its workLife Sciences: 13 fractional works · 32.0% of its workBiochemistry, Genetics and Molecular Biology: 11 fractional works · 25.6% of its workMolecular Biology: 6 fractional works · 14.5% of its workBiotechnology: 2 fractional works · 4.8% of its workCancer Research: 1 fractional works · 2.9% of its workGenetics: 1 fractional works · 1.9% of its workCell Biology: 0 fractional works · 1.2% of its workMolecular Medicine: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workImmunology and Microbiology: 1 fractional works · 3.5% of its workImmunology: 1 fractional works · 2.9% of its workMicrobiology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.3% of its workAgricultural and Biological Sciences: 1 fractional works · 1.6% of its workAquatic Science: 0 fractional works · 0.8% of its workPlant Science: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 1.3% of its workToxicology: 0 fractional works · 0.8% of its workPharmacology: 0 fractional works · 0.5% of its workNeuroscience: 0 fractional works · 0.1% of its workPhysical Sciences: 5 fractional works · 11.4% of its workChemistry: 3 fractional works · 7.0% of its workOrganic Chemistry: 3 fractional works · 7.0% of its workEngineering: 1 fractional works · 1.5% of its workBiomedical Engineering: 1 fractional works · 1.5% of its workComputer Science: 0 fractional works · 0.8% of its workComputational Theory and Mathematics: 0 fractional works · 0.8% of its workMathematics: 0 fractional works · 0.8% of its workStatistics and Probability: 0 fractional works · 0.8% of its workEnvironmental Science: 0 fractional works · 0.4% of its workGlobal and Planetary Change: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workMaterials Science: 0 fractional works · 0.4% of its workBiomaterials: 0 fractional works · 0.4% of its workPhysics and Astronomy: 0 fractional works · 0.3% of its workAtomic and Molecular Physics, and Optics: 0 fractional works · 0.3% of its workEarth and Planetary Sciences: 0 fractional works · 0.2% of its workOceanography: 0 fractional works · 0.2% of its workEnergy: 0 fractional works · 0.1% of its workSocial Sciences: 1 fractional works · 1.9% of its workEconomics, Econometrics and Finance: 0 fractional works · 1.1% of its workEconomics and Econometrics: 0 fractional works · 1.1% of its workPsychology: 0 fractional works · 0.8% of its workClinical Psychology: 0 fractional works · 0.8% of its workALL ITS WORKPharmaMar (Spain)42fractional works, 2022-now
Life Sciences32%Physical Sciences11%Health Sciences55%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 19 fields, with their numbers
    1. Medicine2354.3%
    2. Nursing00.3%
    3. Veterinary00.1%
    1. Biochemistry, Genetics and Molecular Biology1125.6%
    2. Immunology and Microbiology13.5%
    3. Agricultural and Biological Sciences11.6%
    4. Pharmacology, Toxicology and Pharmaceutics11.3%
    5. Neuroscience00.1%
    1. Chemistry37.0%
    2. Engineering11.5%
    3. Computer Science00.8%
    4. Mathematics00.8%
    5. Environmental Science00.4%
    6. Materials Science00.4%
    7. Physics and Astronomy00.3%
    8. Earth and Planetary Sciences00.2%
    9. Energy00.1%
    1. Economics, Econometrics and Finance01.1%
    2. Psychology00.8%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.33× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.81× its world share, 11 worksBiochemistry, Geneti…Immunology and Microbiology: 3.44× its world share, 1 worksImmunology and Micro…Neuroscience: 0.05× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 3.63× its world share, 0 worksPharmacology, Toxico…Chemistry: 4.43× its world share, 3 worksChemistryComputer Science: 0.10× its world share, 0 worksComputer ScienceEarth and Planetary Sciences: 0.13× its world share, 0 worksEarth and Planetary …Energy: 0.10× its world share, 0 worksEnergyEngineering: 0.10× its world share, 1 worksEngineeringEnvironmental Science: 0.09× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.11× its world share, 0 worksMaterials ScienceMathematics: 0.68× its world share, 0 worksMathematicsPhysics and Astronomy: 0.12× its world share, 0 worksPhysics and AstronomyMedicine: 2.82× its world share, 23 worksMedicineNursing: 0.55× its world share, 0 worksNursingVeterinary: 0.98× its world share, 0 worksVeterinaryEconomics, Econometrics and Finance: 0.50× its world share, 0 worksEconomics, Econometr…Psychology: 0.26× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 4.8×. Every wedge is a field page.

All 19 fields, with their numbers
  1. Biochemistry, Genetics and Molecular Biology4.81×11 works
  2. Chemistry4.43×3 works
  3. Pharmacology, Toxicology and Pharmaceutics3.63×0 works
  4. Immunology and Microbiology3.44×1 works
  5. Medicine2.82×23 works
  6. Veterinary0.98×0 works
  7. Mathematics0.68×0 works
  8. Nursing0.55×0 works
  9. Economics, Econometrics and Finance0.50×0 works
  10. Agricultural and Biological Sciences0.33×1 works
  11. Psychology0.26×0 works
  12. Earth and Planetary Sciences0.13×0 works
  13. Physics and Astronomy0.12×0 works
  14. Materials Science0.11×0 works
  15. Computer Science0.10×0 works
  16. Energy0.10×0 works
  17. Engineering0.10×1 works
  18. Environmental Science0.09×0 works
  19. Neuroscience0.05×0 works

Who are the top researchers at PharmaMar (Spain)?

Ranked on the quality score, José María Jimeno, Ali Hassan Zeaiter and Gema Santamaría Núñez lead among researchers whose main affiliation is PharmaMar (Spain).

  1. 1 José María Jimeno Spain · #619,946 worldwide 9.3k citations · 201 works
  2. 2 Ali Hassan Zeaiter Spain · #709,709 worldwide 6.5k citations · 98 works
  3. 3 Gema Santamaría Núñez Spain · #1,143,624 worldwide 616 citations · 40 works
  4. 4 Juan Fernando Martínez-Leal Spain · #1,440,872 worldwide 5.4k citations · 119 works
  5. 5 Alejandro Losada Spain · #1,456,560 worldwide 1.2k citations · 44 works
  6. 6 Juan Carlos Tercero Spain · #1,601,518 worldwide 2.3k citations · 91 works
  7. 7 Carmen Maria Kahatt Spain · #1,624,371 worldwide 3.3k citations · 138 works
  8. 8 Carlos María Galmarini Spain · #1,637,534 worldwide 10k citations · 317 works
  9. 9 Pablo Avilés Spain · #1,642,842 worldwide 1.9k citations · 167 works
  10. 10 Marta Martínez Spain · #2,050,425 worldwide 1.5k citations · 60 works
All ranked researchers at PharmaMar (Spain)

What are the most cited papers from PharmaMar (Spain)?

The most cited paper from PharmaMar (Spain) is "Role of Macrophage Targeting in the Antitumor Activity of Trabectedin" (Giovanni Germano et al., 2013), with 874 citations. Next come "The odyssey of marine pharmaceuticals: a current pipeline perspective" (669) and "Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules" (537).

Most cited papers
#PaperReleasedCitations
1 Role of Macrophage Targeting in the Antitumor Activity of Trabectedin Giovanni Germano et al. · Cancer Cell Open access Feb 2013 874
2 The odyssey of marine pharmaceuticals: a current pipeline perspective Alejandro M. S. Mayer, Keith B. Glaser, Carmen Cuevas et al. · Trends in Pharmacological Sciences 6 Apr 2010 669
3 Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules George D. Demetri, Sant P. Chawla, Margaret von Mehren et al. · Journal of Clinical Oncology Open access 4 Aug 2009 537
4 Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial José Manuel Trigo et al. · The Lancet Oncology 27 Mar 2020 488
5 Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study Federica Grosso, Robin L. Jones, George D. Demetri et al. · The Lancet Oncology 23 Jun 2007 452
All 60 most cited papers, with filters and sorting

Which keywords describe research at PharmaMar (Spain)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Chemotherapy, Clinical Trials, Immunotherapy, Targeted Therapy, Biomarkers, Prognostic Factors, Metastasis and Marine Natural Products.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Chemotherapy7▲ 23×10 topics
  2. Clinical Trials6▲ 21×7 topics
  3. Immunotherapy5▲ 18×8 topics
  4. Targeted Therapy5▲ 52×4 topics
  5. Biomarkers5▲ 16×11 topics
  6. Metastasis4▲ 27×4 topics
  7. Prognostic Factors4▲ 21×5 topics
  8. Marine Natural Products4▲ 207×2 topics
  9. Cancer Therapy3▲ 14×9 topics
  10. Drug Discovery3▲ 36×3 topics
  11. Genomic Profiles3▲ 158×1 topic
  12. Small-Cell Lung Cancer3▲ 158×1 topic
  13. Secondary Metabolites3▲ 86×2 topics
  14. Antibiotics3▲ 74×1 topic
  15. Genome Sequencing3▲ 40×2 topics
  16. Natural Products3▲ 43×1 topic
  17. Pharmacology3▲ 26×5 topics
  18. Cancer2▲ 4.0×15 topics
  19. Genomic Profiling2▲ 52×2 topics
  20. Inflammation2▲ 2.4×15 topics
  21. Genetic Mutations2▲ 10×5 topics
  22. ALK Inhibitors2▲ 68×1 topic
  23. EGFR Mutations2▲ 68×1 topic
  24. Hematological Malignancies2▲ 104×2 topics
  25. DNA1▲ 200×1 topic
  26. Topoisomerases1▲ 200×1 topic
  27. Tumor Microenvironment1▲ 7.6×6 topics
  28. Tumor Targeting1▲ 18×3 topics
  29. Microbial Symbionts1▲ 199×1 topic
  30. Precision Medicine1▲ 5.7×5 topics
  31. Sponge-Associated Microorganisms1▲ 199×1 topic
  32. Anticancer Agents1▲ 18×4 topics
  33. PET Imaging1▲ 15×4 topics
  34. Survival Analysis1▲ 9.3×2 topics
  35. Total Synthesis1▲ 79×2 topics
  36. Transcriptional Regulation1▲ 15×2 topics
  37. Tumor Regression1▲ 24×2 topics
  38. Cell Death1▲ 10×2 topics
  39. Neuroendocrine Tumors1▲ 77×1 topic
  40. Pancreatic Neuroendocrine Tumors1▲ 77×1 topic

Which research topics does PharmaMar (Spain) publish most on?

By volume in 2022-now: Lung Cancer Research Studies, Microbial Natural Products and Biosynthesis, Lung Cancer Treatments and Mutations and Cancer therapeutics and mechanisms.

  1. 1 Lung Cancer Research Studies Oncology 3 works
  2. 2 Microbial Natural Products and Biosynthesis Pharmacology 3 works
  3. 3 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
  4. 4 Cancer therapeutics and mechanisms Molecular Biology 1 works
  5. 5 Marine Sponges and Natural Products Biotechnology 1 works
  6. 6 Pharmaceutical Practices and Patient Outcomes Geriatrics and Gerontology 1 works
  7. 7 Neuroendocrine Tumor Research Advances Epidemiology 1 works
  8. 8 Protein Degradation and Inhibitors Molecular Biology 1 works
  9. 9 PARP inhibition in cancer therapy Oncology 1 works
  10. 10 Sarcoma Diagnosis and Treatment Pulmonary and Respiratory Medicine 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available29.9%not open70.1%

World: 40% of research is openly available.

with international co-authors36.4%domestic only63.6%

World: 18% is written across borders.

How has PharmaMar (Spain)'s research output changed?

Output in 2022-2025 was 14% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is PharmaMar (Spain) as a percentage of every work published that year, 0.00015% in 2024.

still counting0.00050%0.0010%0.0015%PharmaMar (Spain)0.00019% in 20251990200020102020

Fractional works of PharmaMar (Spain) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Madrid

All research institutions in Madrid

Share PharmaMar (Spain)'s ranking

PharmaMar (Spain) on Science Explorer

A card with PharmaMar (Spain)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about PharmaMar (Spain). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.